(BMRN) Real-time Estimate Cboe BZX - 01:36:55 2023-04-28 pm EDT 95.32 USD +3.10% 01:28p BIOMARIN PHARMACEUTICAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) AQ 04/27 Piper Sandler Adjusts BioMarin Pharmaceutical's Price Target to $125 From $128, Keeps Overweight Rating MT 04/27 Guggenheim Adjusts Price Target on BioMarin Pharmaceutical to $120 From $125, Maintains Buy Rating MT Summary Quotes Charts News Ratings Calendar Company...